152 related articles for article (PubMed ID: 22204431)
1. Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications.
Kolmar H
Curr Pharm Des; 2011 Dec; 17(38):4329-36. PubMed ID: 22204431
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
Avrutina O
Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
[TBL] [Abstract][Full Text] [Related]
3. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
Kolmar H
Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
[TBL] [Abstract][Full Text] [Related]
4. Engineered cystine-knot miniproteins for diagnostic applications.
Kolmar H
Expert Rev Mol Diagn; 2010 Apr; 10(3):361-8. PubMed ID: 20370592
[TBL] [Abstract][Full Text] [Related]
5. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
Kolmar H
FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and MALDI-TOF Mass Spectrometric Characterization of a Novel Native and Recombinant Cystine Knot Miniprotein from Solanum tuberosum subsp. andigenum cv. Churqueña.
Cotabarren J; Tellechea ME; Tanco SM; Lorenzo J; Garcia-Pardo J; Avilés FX; Obregón WD
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495576
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.
Reinwarth M; Nasu D; Kolmar H; Avrutina O
Molecules; 2012 Oct; 17(11):12533-52. PubMed ID: 23095896
[TBL] [Abstract][Full Text] [Related]
8. Cystine-knot peptides: emerging tools for cancer imaging and therapy.
Ackerman SE; Currier NV; Bergen JM; Cochran JR
Expert Rev Proteomics; 2014 Oct; 11(5):561-72. PubMed ID: 25163524
[TBL] [Abstract][Full Text] [Related]
9. Targeting the tumor vasculature with engineered cystine-knot miniproteins.
Lui BG; Salomon N; Wüstehube-Lausch J; Daneschdar M; Schmoldt HU; Türeci Ö; Sahin U
Nat Commun; 2020 Jan; 11(1):295. PubMed ID: 31941901
[TBL] [Abstract][Full Text] [Related]
10. Plant cystine-knot peptides: pharmacological perspectives.
Molesini B; Treggiari D; Dalbeni A; Minuz P; Pandolfini T
Br J Clin Pharmacol; 2017 Jan; 83(1):63-70. PubMed ID: 26987851
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer.
Kimura RH; Teed R; Hackel BJ; Pysz MA; Chuang CZ; Sathirachinda A; Willmann JK; Gambhir SS
Clin Cancer Res; 2012 Feb; 18(3):839-49. PubMed ID: 22173551
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.
Glotzbach B; Reinwarth M; Weber N; Fabritz S; Tomaszowski M; Fittler H; Christmann A; Avrutina O; Kolmar H
PLoS One; 2013; 8(10):e76956. PubMed ID: 24146945
[TBL] [Abstract][Full Text] [Related]
13. Engineering knottins as novel binding agents.
Moore SJ; Cochran JR
Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571
[TBL] [Abstract][Full Text] [Related]
14. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
[TBL] [Abstract][Full Text] [Related]
15. Fragmentation follows structure: top-down mass spectrometry elucidates the topology of engineered cystine-knot miniproteins.
Reinwarth M; Avrutina O; Fabritz S; Kolmar H
PLoS One; 2014; 9(10):e108626. PubMed ID: 25303319
[TBL] [Abstract][Full Text] [Related]
16. The cystine knot motif in toxins and implications for drug design.
Craik DJ; Daly NL; Waine C
Toxicon; 2001 Jan; 39(1):43-60. PubMed ID: 10936622
[TBL] [Abstract][Full Text] [Related]
17. A cystine-knot miniprotein from tomato fruit inhibits endothelial cell migration and angiogenesis by affecting vascular endothelial growth factor receptor (VEGFR) activation and nitric oxide production.
Treggiari D; Zoccatelli G; Molesini B; Degan M; Rotino GL; Sala T; Cavallini C; MacRae CA; Minuz P; Pandolfini T
Mol Nutr Food Res; 2015 Nov; 59(11):2255-66. PubMed ID: 26255647
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins.
Reiss S; Sieber M; Oberle V; Wentzel A; Spangenberg P; Claus R; Kolmar H; Lösche W
Platelets; 2006 May; 17(3):153-7. PubMed ID: 16702041
[TBL] [Abstract][Full Text] [Related]
19. Structure and modeling of knottins, a promising molecular scaffold for drug discovery.
Gracy J; Chiche L
Curr Pharm Des; 2011 Dec; 17(38):4337-50. PubMed ID: 22204432
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effects of two cystine-knot miniproteins from tomato fruit.
Cavallini C; Trettene M; Degan M; Delva P; Molesini B; Minuz P; Pandolfini T
Br J Pharmacol; 2011 Mar; 162(6):1261-73. PubMed ID: 21175567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
